Cargando…
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation
Combined antiretroviral therapy (cART) for HIV-1 dramatically slows disease progression among HIV(+) individuals. Currently, lymphoma represents the main cause of death among HIV-1-infected patients. Detection of p17 variants (vp17s) endowed with B-cell clonogenic activity in HIV-1-seropositive pati...
Autores principales: | Giagulli, Cinzia, Caccuri, Francesca, Zorzan, Simone, Bugatti, Antonella, Zani, Alberto, Filippini, Federica, Manocha, Ekta, D’Ursi, Pasqualina, Orro, Alessandro, Dolcetti, Riccardo, Caruso, Arnaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203498/ https://www.ncbi.nlm.nih.gov/pubmed/33093643 http://dx.doi.org/10.1038/s41417-020-00246-9 |
Ejemplares similares
-
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17
por: Giagulli, Cinzia, et al.
Publicado: (2017) -
Binding to PI(4,5)P(2) is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants
por: Bugatti, Antonella, et al.
Publicado: (2021) -
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin
por: Caccuri, Francesca, et al.
Publicado: (2021) -
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
por: Bugatti, Antonella, et al.
Publicado: (2019) -
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion
por: Manocha, Ekta, et al.
Publicado: (2021)